RNase MC2: a new Momordica charantia ribonuclease that induces apoptosis in breast cancer cells associated with activation of MAPKs and induction of caspase pathways.

MLA

Fang, Evandro Fei, et al. “RNase MC2: A New Momordica Charantia Ribonuclease That Induces Apoptosis in Breast Cancer Cells Associated with Activation of MAPKs and Induction of Caspase Pathways.” Apoptosis : An International Journal on Programmed Cell Death, vol. 17, no. 4, Apr. 2012, pp. 377–87. EBSCOhost, https://doi.org/10.1007/s10495-011-0684-z.

APA

Fang, E. F., Zhang, C. Z. Y., Fong, W. P., & Ng, T. B. (2012). RNase MC2: a new Momordica charantia ribonuclease that induces apoptosis in breast cancer cells associated with activation of MAPKs and induction of caspase pathways. Apoptosis : An International Journal on Programmed Cell Death, 17(4), 377–387. https://doi.org/10.1007/s10495-011-0684-z

Chicago

Fang, Evandro Fei, Chris Zhi Yi Zhang, Wing Ping Fong, and Tzi Bun Ng. 2012. “RNase MC2: A New Momordica Charantia Ribonuclease That Induces Apoptosis in Breast Cancer Cells Associated with Activation of MAPKs and Induction of Caspase Pathways.” Apoptosis : An International Journal on Programmed Cell Death 17 (4): 377–87. doi:10.1007/s10495-011-0684-z.